Plasma β-amyloid in Alzheimer's disease and vascular disease
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Implementation of amyloid biomarkers in clinical practice would be accelerated if such biomarkers could be measured in blood. We analyzed plasma levels of Aβ42 and Aβ40 in a cohort of 719 individuals (the Swedish BioFINDER study), including patients with subjective cognitive decline (SCD), mild cognitive impairment (MCI), Alzheimer’s disease (AD) dementia and cognitively healthy elderly, using a ultrasensitive immunoassay (Simoa platform). There were weak positive correlations between plasma and cerebrospinal fluid (CSF) levels for both Aβ42 and Aβ40, and negative correlations between plasma Aβ42 and neocortical amyloid deposition (measured with PET). Plasma levels of Aβ42 and Aβ40 were reduced in AD dementia compared with all other diagnostic groups. However, during the preclinical or prodromal AD stages (i.e. in amyloid positive controls, SCD and MCI) plasma concentration of Aβ42 was just moderately decreased whereas Aβ40 levels were unchanged. Higher plasma (but not CSF) levels of Aβ were associated with white matter lesions, cerebral microbleeds, hypertension, diabetes and ischemic heart disease. In summary, plasma Aβ is overtly decreased during the dementia stage of AD indicating that prominent changes in Aβ metabolism occur later in the periphery compared to the brain. Further, increased levels of Aβ in plasma are associated with vascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Correlations between plasma and CSF Aβ and between plasma Aβ and [18F]flutemetamol SUVR. (A–C) Plasma (Simoa immunoassay) and CSF (Euroimmun immunoassay) Aβ42 and Aβ40 were measured in a cohort of 719 individuals (174 SCI, 214 MCI, 57 AD patients and 274 controls). (D–F) Neuocortical amyloid deposition was measured using [18F]flutemetamol PET in a cohort of 340 individuals (103 SCI, 112 MCI patients and 125 controls). Correlation coefficients (r) and p-values are from Pearson’s correlation analysis. AD, Alzheimer’s disease; CSF, cerebrospinal fluid; SCD, subjective cognitive decline; MCI, mild cognitive impairment; PET, positron emission tomography; SUVR, standardized uptake value ratio.](https://figures.cochat.ai/paper-figures/71bfab0f50314c6182d3ebedc2d5d0c6/plasma-amyloid-in-alzheimer-s-disease-and-vascular-disease-figure-1.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“more recent studies have demonstrated that it correlates with brain Aβ and can differentiate patients with AD from healthy control participants.12,13”
From Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many candidate blood biomarkers have failed in replication studies,7,8 but somewhat promising results have been seen for plasma tau, neurofilament light chain (NFL), and combinations of Aβ42 and Aβ40.9,10,11,12,13,14,15,16,17”
From Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“a 65-year-old woman with only amyloid biomarkers but who is cognitively normal and has no neurodegeneration has a 10-year Alzheimer's disease risk of 2·5% and a man 2·3%, but the risk is higher with accompanying neurodegeneration (table 2 ).185”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [185]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“A model of lifetime risks of people who are amyloid positive without any other biomarkers finds it to be 8·4% for a 90-year-old woman who is cognitively normal at baseline, 23·5% for a 75-year-old woman and 29·3% for a 65-year-old woman.185”
From Dementia prevention, intervention, and care: 2020 report of the Lancet Commission (2020) · cites this paper as [185]
Experimental — accuracy not yet measuredIn the citing paper
“Although previous studies have found associations between CSF and PET Aβ and plasma Aβ using different immunoassays,7,12,13,14,44,45 the present Elecsys assays produced among the best accuracies and they are the first fully automated assays to have these greater accuracies.”
From Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease–Related β-Amyloid Status (2019) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Jack, C. R., Knopman, D. S., Jagust, W. J., Petersen, R. C., Weiner, M. W., Aisen, P. S., Shaw, L. M., Vemuri, P., Wiste, H. J., Weigand, S. D., et al. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70291-0 · Cited by 4,396
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321
Self-citationRissin, D. M., Kan, C. W., Campbell, T. G., Howes, S. C., Fournier, D. R., Song, L., Piech, T., Patel, P. P., Chang, L., Rivnak, A. J., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1641 · Cited by 2,119
Self-citationCerebrospinal fluid and plasma biomarkers in Alzheimer disease
Blennow, K., Hampel, H., Weiner, M., & Zetterberg, H. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.4 · Cited by 1,863
Self-citationA New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT
Wahlund, L. O., Barkhof, F., Fazekas, F., Bronge, L., Augustin, M., Sjögren, M., Wallin, A., Ader, H., Leys, D., Pantoni, L., et al. (2001) · Stroke · doi:10.1161/01.str.32.6.1318 · Cited by 1,797
Plasma phospholipids identify antecedent memory impairment in older adults
Mapstone, M., Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3466 · Cited by 1,043
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zlokovic, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 860
Research works printed but not linked: 1
- Janelidze, S. et al. CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease. Annals of Clinical and Translational Neurology (In press).
Cited by
Items 501–600 of 628
Zhang, S., Zhang, L., Ma, L., Wu, H., Liu, L., He, X., Gao, M., & Li, R. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1302281 · Cited by 2
Farhadieh, M., Mozafar, M., Sanaaee, S., Sodeifi, P., Kousha, K., Zare, Y., Zare, S., Rad, N. M., Goharrizi, F. J., Allahverdloo, M., et al. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105576 · Cited by 2
Tan, M. S., Cheah, P., Chin, A., Looi, L., & Chang, S. (2024) · PeerJ · doi:10.7717/peerj.17643 · Cited by 2
The biological diagnosis of Alzheimer’s disease using blood-based biomarkers: A Canadian prospective
Kumar, P., Mousavi, A., & Frykman, H. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.110980 · Cited by 2
Fluid Biomarkers in Alzheimer’s Disease and Frontotemporal Dementia
Mattsson, N., Grigoriou, S., & Zetterberg, H. (2018) · Springer eBooks · doi:10.1007/978-3-319-72938-1_11 · Cited by 4
Self-citationFluid biomarkers for Alzheimer's disease in Down syndrome: Current status and novel trends
Iulita, M. F., Granholm, A., Carmona‐Iragui, M., Hamlett, E. D., Fortea, J., & Ledreux, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00010-4 · Cited by 3
Blennow, K., & Zetterberg, H. (2022) · International perspectives on aging · doi:10.1007/978-3-030-78063-0_7 · Cited by 3
Self-citationDuff, E. P., Zetterberg, H., Heslegrave, A., Dehghan, A., Elliott, P., Allen, N. E., Runz, H., Laban, R., Veleva, E., Whelan, C. D., et al. (2024) · medRxiv · doi:10.1101/2024.02.02.24302132 · Cited by 2
Self-citationAnastasi, F., Fernández‐Lebrero, A., Ashton, N. J., Ortiz-Romero, P. L., Torres‐Torronteras, J., González‐Escalante, A., Milà‐Alomà, M., Contador, J., García‐Escobar, G., Manero-Borràs, R. M., et al. (2024) · medRxiv · doi:10.1101/2024.10.26.24316176 · Cited by 2
Self-citationBiomarkers for Alzheimer's Disease: Early Diagnosis
Panwar, D., Sharma, P., Sharma, S., Malik, M., & Kaur, J. (2024) · Advances in bioinformatics and biomedical engineering book series · doi:10.4018/979-8-3693-6442-0.ch003 · Cited by 1
Effect of Initiation With Sacubitril/valsartan on Blood Neurodegeneration Markers in HFrEF
Prausmüller, S., Wurm, R., Ponleitner, M., Stögmann, E., Hülsmann, M., & Pávó, N. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.01.021 · Cited by 1
McFarlane, O., Kozakiewicz, M., Kędziora–Kornatowska, K., Gałęska-Śliwka, A., & Wojciechowska, M. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47030203 · Cited by 1
Carrera, I., Naidoo, V., Corzo, L., Martínez-Iglesias, O. A., & Cacabelos, R. (2025) · Genes · doi:10.3390/genes16101214 · Cited by 1
Rao, D. M., Biswas, S. K., & Bordoloi, M. (2025) · Archives of Computational Methods in Engineering · doi:10.1007/s11831-025-10440-3 · Cited by 2
Plasma biomarkers in neuropsychiatric syndromes: A narrative review
Ismail, Z., Guan, D. X., Babulal, G. M., Bateman, J. R., Cantillon, M., Creese, B., D’Antonio, F., Fischer, C. E., Gatchel, J. R., Ghahremani, M., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251392185 · Cited by 4
PET imaging utility of a novel Aβ-tracking PET radiotracer, [18F]FC119S in aged vervet monkeys
Bhoopal, B., Frye, B. M., Miller, M. D., Bansode, A. H., Gollapelli, K. K., Barcus, R. A., Lockhart, S. N., Damuka, N., Sutphen, C. L., Fitzgerald, R. W., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-025-07642-5 · Cited by 3
Cánovas, R., Cox, T. O., Doré, V., Bourgeat, P., Fripp, J., Feizpour, A., Shishegar, R., Fowler, C. J., Laws, S. M., Porter, T., et al. (2026) · Annals of Neurology · doi:10.1002/ana.78163 · Cited by 4
de la Garza, Á. G., Wang, C., Derby, C. A., Gao, Q., Ye, K. Q., Zetterberg, H., Engeland, C. G., Lipton, R. B., & Katz, M. J. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261426582 · Cited by 1
Self-citationDelgado, A., Davidson, K., Parker, D. J., Bryant, J., Winstead, V., Yildiz, M., Pickering, C., & Pickering, A. M. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-02040-5 · Cited by 1
Diabetes, hyperglycemia, and ATN blood biomarkers in Hispanic/Latino populations: SOL‐INCA study
González, K. A., Tarraf, W., Pa, J., Banks, S. J., Bangen, K. J., Galasko, D. R., Gallo, L. C., Stickel, A. M., Anita, N. Z., Márquez, F., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71223 · Cited by 1
Rajalakshmi, R., M., R. C., Naaz, R., Madhunapantula, S. V., Uthaiah, C. A., & Salimath, P. V. (2026) · Frontiers in Aging · doi:10.3389/fragi.2026.1696711 · Cited by 1
Alam, A., Bushra, Zainab, Ayaz, M., Elhenawy, A. A., Rehman, N. U., Rasheed, L., Ahmad, I., Ali, M., Latif, A., et al. (2026) · Pure and Applied Chemistry · doi:10.1515/pac-2026-0753 · Cited by 1
Plasma biomarkers for Alzheimer's disease among middle-aged individuals
Rosenberg, A., & Ngandu, T. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00692-6 · Cited by 1
Chen, H. B., Guo, Y. P., Huang, W., Hu, A., Liu, T., & Chen, F. (2026) · Psychological Medicine · doi:10.1017/s0033291726105005 · Cited by 1
Chien, S.-C., Chang, I.-Y., Chen, Y., Lai, Y.-Z., Chen, Y., Sun, P., Li, B., Wang, Y., & Chen, J.-C. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345949 · Cited by 1
Ruchisrisarod, C., Kaewpom, T., Wanthong, P., Luechaipanit, W., Bunprakob, S., Ampoot, W., Yomrat, S., Hemachudha, P., Supharatpariyakorn, T., Thanapornsangsuth, P., et al. (2026) · International Journal of Immunopathology and Pharmacology · doi:10.1177/03946320261465568 · Cited by 1
Searching for Neurodegeneration in the Blood of Patients With Alzheimer Disease
Galasko, D. R. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.0010 · Cited by 1
Bioinformatic analysis of biological pathways in coronary heart disease and Alzheimer’s disease
Chasovskikh, N. Y., & Chizhik, E. E. (2023) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2022-4-193-204 · Cited by 1
Goodman, M., Li, X. R., Livschitz, J., Huang, C., Bendlin, B. B., Granadillo, E. D., & Initiative, A. D. N. (2023) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230054 · Cited by 1
Ataka, T., Kimura, N., Kaneko, N., Masuda, T., Takeuchi, Y., Yabuuchi, K., Mizukami, T., Takeuchi, T., Ito, T., Tasai, H., et al. (2024) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70008 · Cited by 3
Biomarkers used in Alzheimer's disease diagnosis
Mishra, S. K., Singh, R., Chang, H., Obaid, A. A., & Singh, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00013-6 · Cited by 1
Liu, Y., Liu, X., Che, P., Wang, Y., Piao, Z., Wang, Y., Cai, L., Xing, M., Xu, Y., Sun, W., et al. (2025) · Scientific Reports · doi:10.1038/s41598-024-83919-x · Cited by 2
Fan, X., Ye, X., Xu, J., Mao, T., Zhang, R., Zhou, X., Yeung, C. C. K. A., Li, C., Chang, R. C., Lin, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202509376 · Cited by 3
Choi, Y., Ha, S.-M., Kim, J.-S., Koh, S.-H., & Kim, D. (2020) · 한국여성체육학회지 · doi:10.16915/jkapesgw.2020.6.34.2.121 · Cited by 1
Emerging blood-based biomarkers for Alzheimer disease
Bekris, L. M., & Leverenz, J. B. (2020) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.87a.20133 · Cited by 1
A blood-based signature of cerebrospinal fluid A β 1–42 statusPreprint
Goudey, B., Fung, B. J., Schieber, C., Initiative, A. D. N., & Faux, N. G. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/190207 · Cited by 1
Laboratory diagnostics in dementia
Weber, T. (2018) · Journal of Laboratory Medicine · doi:10.1515/labmed-2018-0047 · Cited by 3
Whittaker, D. S., Akhmetova, L., Romero, H. K., Welsh, D. K., Colwell, C. S., & Desplats, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.07.511346 · Cited by 1
Mhatre‐Winters, I., Eid, A., Blum, N., Han, Y., Sammoura, F. M., Wu, L., & Richardson, J. R. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.14.638293 · Cited by 1
Diagnostiek van de ziekte van Alzheimer
van der Flier, W. M. (2018) · Neuropraxis · doi:10.1007/s12474-018-00205-z
Яхьяевич, Я. Н., & Vagabov, N. M. (2009) · VESTNIK OF ASTRAKHAN STATE TECHNICAL UNIVERSITY SERIES MARINE ENGINEERING AND TECHNOLOGIES · Cited by 1
Recent advances in blood and gut microbiota biomarkers for Alzheimer’s disease
Wu, S., Li, H., Tong, L., & Zhou, L. I. U. (2021) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0100
Vorobev, S. V., Yanishevskij, S. N., Emelin, А. Y., Lebedev, A. A., Лебедев, С. П., Makarov, Y. N., Усиков, А. С., Klotchenko, S. A., & Vasin, A. V. (2022) · Russian Clinical Laboratory Diagnostics · doi:10.51620/0869-2084-2022-67-1-5-12 · Cited by 1
Performance of plasma amyloid, tau, and astrocyte biomarkers to identify cerebral AD pathophysiologyPreprint
Ferreira, P. C. L., Tissot, C., Ferrari‐Souza, J. P., Brum, W. S., Bellaver, B., Leffa, D. T., Therriault, J., Benedet, A. L., Lussier, F. Z., Chamoun, M., et al. (2022) · medRxiv · doi:10.1101/2022.02.21.22271198
Self-citationDevelopment of Fluid Biomarkers for Alzheimer’s Disease
Blennow, K. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108975759.033 · Cited by 1
Self-citationGillespie, N. A., Rissman, R. A., Elman, J. A., McKenzie, R. E., Tu, X. M., Xian, H., Reynolds, C. A., Panizzon, M. S., Lyons, M. J., Eglit, G. M. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.503234
Weiner, M. W. (2022) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2022.94
Research and Prospect of Blood Biomarkers for Alzheimer’s Disease
蓝, 萍. (2023) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2023.131002
Nielsen, J. E., Andreassen, T., Gotfredsen, C. H., Olsen, D. A., Vestergaard, K., Madsen, J. S., Kristensen, S. R., & Pedersen, S. (2023) · Research Square · doi:10.21203/rs.3.rs-2765583/v1
Potential Biomarkers for Early Diagnosis of Alzheimer’s Disease and Primary Open-Angle Glaucoma
Bogolepova, A. N., Makhnovich, E. V., Коваленко, Е. А., & Osinovskaya, N. A. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01449-x
Jing, X., Wang, L., Song, M. L., Geng, H., Li, W., Huo, Y., Huang, A., Wang, X., & An, C. (2024) · Research Square · doi:10.21203/rs.3.rs-3828911/v1
Towards in vivo MRI-based diagnostics and tracking of dementia
Ortega‐Cruz, D. (2024) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.81334
Oh, E. J., Lee, J. J., Jung, B. K., & Kim, J. K. (2024) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2024.26.32
Gillespie, N. A., Neale, M. C., Panizzon, M. S., McKenzie, R. E., Tu, X. M., Xian, H., Reynolds, C. A., Lyons, M. J., Rissman, R. A., Elman, J. A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.23.602498
Biomarkers for presymptomatic diagnosis and prognosis
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00001-2
Biomarkers in Alzheimer’s Disease: Structure and Assays
Gezen‐Ak, D., Alaylioglu, M., Çamoğlu, T., Yurttaş, Z., Şengül, B., & Dursun, E. (2024) · doi:10.69860/nobel.9786053359166.6
Emerging Biomarkers for Early Detection of Alzheimer’s Disease: A Systematic ReviewPreprint
Desai, C., Rathod, S., Daulti, T., Prajapati, M., Malkan, S., & Bhamwani, M. (2024) · medRxiv · doi:10.1101/2024.10.16.24315604 · Cited by 1
Jia, D., He, T., Sun, L., Wang, Q., & Yu, H. (2024) · Current Alzheimer Research · doi:10.2174/0115672050339307241108101528
Wang, L., Li, Y., Hu, Y., Li, L., Jia, N., Chen, Y., Meng, Y., Ye, J., & Li, N. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1429088
New Research on Biomarkers in Alzheimer’s Continuum
Vecchio, I., & Colica, C. (2025) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871331138250114052615 · Cited by 3
Fluid-based biomarkers in neurodegeneration: Current findings and future directions
Blagojević, S., Jeremić, M., & Marković, I. (2024) · Medicinski podmladak · doi:10.5937/mp75-54180
Skin Biomarkers of Neurodegenerative Diseases
Reilly-Jankowiak, L., Bargar, C., Bunn, D., & Chen, S. G. (2025) · Springer eBooks · doi:10.1007/978-3-031-66513-4_6
Fortschritte und Herausforderungen der Alzheimer-Diagnostik
Findeisen, P. (2025) · Trillium Diagnostik · doi:10.47184/td.2025.01.07
Advances in fluid-based biomarkers
Zetterberg, H. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822240-9.00008-9
Self-citationGillespie, N. A., Neale, M. C., Panizzon, M. S., McKenzie, R. E., Tu, X. M., Xian, H., Reynolds, C. A., Lyons, M. J., Rissman, R. A., Elman, J. A., et al. (2025) · Aging Brain · doi:10.1016/j.nbas.2025.100139
Abbasi, A. A., Ayers, L., Balczon, R., Nelson, A. R., Bauman, A. J., Cohen, M., Abadi, N., Priest, J. R., Vallabhajosyula, S., Baird, G. L., et al. (2025) · CHEST Critical Care · doi:10.1016/j.chstcc.2025.100170
Ghahremani, M., Leon, R., Vellone, D. A., Guan, D. X., Hosseinpour, Z., Crockford, J. F. E., Azhar, S., Sharif, S. F., Warring, I., & Ismail, Z. (2025) · Springer eBooks · doi:10.1007/978-3-031-80849-4_17
The biological diagnosis of Alzheimer’s disease using blood-based biomarkers: a Canadian prospective
Kumar, P., Mousavi, A., & Frykman, H. (2025) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2025.111015 · Cited by 1
Rao, D. M., Biswas, S. K., & Tripathi, D. (2025) · International Conference on Computing, Intelligence, and Application (CIACON) · doi:10.1109/ciacon65473.2025.11189446
Qin, W., Yu, L., Wang, M., Wang, M., Lin, L., Zhang, Q., Yang, F., & He, G. (2025) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x408846251007045430
Rad, A. R., Nadaki, A., Khosravi, F., Nasiri, H., Ghayourvahdat, A., & Initiative, A. D. N. (2025) · Scientific Reports · doi:10.1038/s41598-025-32404-0 · Cited by 1
Meyer, S. D., Schaeverbeke, J. M., Verberk, I. M. W., Gille, B., Schaepdryver, M. D., Luckett, E. S., Gabel, S., Bruffaerts, R., Mauroo, K., Thijssen, E. H., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13337729
Hirtz, C., Busto, G. U., Bennys, K., Kindermans, J., Navucet, S., Tiers, L., Lista, S., Vialaret, J., Gutierrez, L., Dauvilliers, Y. A., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22598948
Johansson, C., Þórðardóttir, S., Laffita-Mesa, J., Pannee, J., Rodriguez‐Vieitez, E., Zetterberg, H., Blennow, K., & Graff, C. (2024) · Figshare · doi:10.6084/m9.figshare.27107560
Self-citationSandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612336
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612333
Verberk, I. M. W., Thijssen, E. H., Koelewijn, J., Mauroo, K., Vanbrabant, J., de Wilde, A., Zwan, M. D., Verfaillie, S. C. J., Ossenkoppele, R., Barkhof, F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13018138
Dark, H. E., An, Y., Duggan, M. R., Joynes, C. M., Davatzikos, C. A., Erus, G., Lewis, A., Moghekar, A. R., Resnick, S. M., & Walker, K. A. (2024) · Figshare · doi:10.6084/m9.figshare.26714290
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612327
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612324
Prins, S., Zhuparris, A., Hart, E. P., Doll, R.-J., & Groeneveld, G. J. (2021) · Figshare · doi:10.6084/m9.figshare.15000164
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612348
Sandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612330
Dark, H. E., An, Y., Duggan, M. R., Joynes, C. M., Davatzikos, C. A., Erus, G., Lewis, A., Moghekar, A. R., Resnick, S. M., & Walker, K. A. (2024) · Figshare · doi:10.6084/m9.figshare.26714287
Benedet, A. L., Brum, W. S., Hansson, O., Karikari, T. K., Zimmer, E. R., Zetterberg, H., Blennow, K., & Ashton, N. J. (2022) · Figshare · doi:10.6084/m9.figshare.19135820
Self-citationSandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612345
Brand, A. L., Lawler, P. E., Bollinger, J. G., Li, Y., Schindler, S. E., Li, M., Lopez, S., Ovod, V., Nakamura, A., Shaw, L. M., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603541
Self-citationSandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612342
Dark, H. E., An, Y., Duggan, M. R., Joynes, C. M., Davatzikos, C. A., Erus, G., Lewis, A., Moghekar, A. R., Resnick, S. M., & Walker, K. A. (2024) · Figshare · doi:10.6084/m9.figshare.26714284
Pascual‐Lucas, M., Allué, J. A., Sarasa, L., Fandos, N., Castillo, S., Terencio, J. V., Sarasa, M., Tartari, J. P., Sanabria, Á., Tárraga, L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22612958
Andersson, E., Schultz, N., Saito, T., Saido, T. C., Blennow, K., Gouras, G. K., Zetterberg, H., & Hansson, O. (2023) · Figshare · doi:10.6084/m9.figshare.22620482
Self-citationSandberg, A., Berenjeno-Correa, E., Rodriguez, R. C., Axenhus, M., Weiss, S. S., Batenburg, K. L., Hoozemans, J. J. M., Tjernberg, L. O., & Scheper, W. (2023) · Figshare · doi:10.6084/m9.figshare.22612339
Cross-Validation of Neurodegeneration Biomarkers in Blood and CSF for Dementia Classification
Ochneva, A., Abramova, O. V., Zorkina, Y., Morozova, I., Ushakova, V. M., Ka, P., Andreyuk, D., Zubkov, E., Andryushchenko, A. V., Tsurina, A. M., et al. (2026) · Clinical and Translational Neuroscience · doi:10.3390/ctn10010002
An integrated CSF-serum biomarker model for predicting clinical progression in Alzheimer’s disease
Wang, X., Tang, Y., Zhang, Q., Xiang, B., Zeng, S., Zhang, Q., Gu, M., & Zou, L. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1728675
Blood-based emerging biomarkers in early detection and diagnosis of Alzheimer’s disease
Anand, T., & Kumar, A. (2026) · International review of neurobiology · doi:10.1016/bs.irn.2026.01.002
Rao, A. R., Pradhan, R., Anwar, M., Gupta, A., Bhagwasia, M., Nichols, E., Gross, A. L., Thyagarajan, B., Hu, P., Crimmins, E. M., et al. (2026) · Journal of the American Geriatrics Society · doi:10.1111/jgs.70339 · Cited by 1
Verma, M., Raikwar, S., Beohar, M., Vishwakarma, N., & Sil, A. J. (2026) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898814021126010004
Baek, H.-I., Joo, J. C., Kim, S.-K., Park, M.-H., Cho, G. H., Shen, L., & Park, S. J. (2026) · Nutrients · doi:10.3390/nu18060960
Chien, S.-C., Chang, C.-H., Lee, C.-Y., Fu, Y., & Chen, J.-C. (2026) · ACS Applied Nano Materials · doi:10.1021/acsanm.6c00887
Qiu, Q., Qian, W., Zhao, W., Xie, H., Cao, L., Ye, L., & Initiative, A. D. N. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261439687
Metadata
- Authors
- Janelidze, S., Stomrud, E., Palmqvist, S., Zetterberg, H., van Westen, D., Jeromin, A., Song, L., Hanlon, D., Tan Hehir, C. A., Baker, D., Blennow, K., & Hansson, O.
- Affiliations
- Lund University (SE)
- National Hospital for Neurology and Neurosurgery (GB)
- Quanterix (United States) (US)
- University of Gothenburg (SE)
- Corresponding author
- Janelidze, Shorena
- Hansson, Oskar
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-05-31
- Volume
- 6
- Issue
- 1
- Pages
- 26801-26801
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4886210
- OpenAlex
- W2414917913
- Cited by
- 626
- References
- 49
- Citations by year
- 2026: 53 · 2025: 59 · 2024: 75 · 2023: 77 · 2022: 80 · 2021: 75 · 2020: 73 · 2019: 59 · 2018: 45 · 2017: 22 · 2016: 6
- FWCI
- 39.10
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Australian Government
- Crafoordska Stiftelsen
- Lunds Universitet
- Vetenskapsrådet
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- plasma amyloid-beta, amyloid-beta 42, Aβ40, Alzheimer's disease, vascular disease, amyloid biomarkers, cerebrospinal fluid, white matter lesions, cerebral microbleeds, hypertension, diabetes mellitus, ischemic heart disease, mild cognitive impairment, subjective cognitive decline, amyloid PET, amyloid metabolism
- MeSH terms
- Aged, Alzheimer Disease, Female, Humans, Male, Vascular Diseases, Cohort Studies, Biomarkers, Amyloid beta-Peptides, Neocortex, Positron-Emission Tomography, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.